Ascom Holding AG (ACMLF)
USD 3.64
(-44.0%)
USD 3.64
(-44.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 22.2 Million CHF | 16.93% |
| 2022 | 25.4 Million CHF | -17.8% |
| 2021 | 30.9 Million CHF | 35.53% |
| 2020 | 22.8 Million CHF | 98.26% |
| 2019 | 12.6 Million CHF | -71.18% |
| 2018 | 30.6 Million CHF | -9.93% |
| 2017 | 36.9 Million CHF | 211.97% |
| 2016 | -130.8 Million CHF | -69.66% |
| 2015 | 49.4 Million CHF | -26.53% |
| 2014 | 68.2 Million CHF | 2.25% |
| 2013 | 65.2 Million CHF | 46.59% |
| 2012 | 47.2 Million CHF | -31.67% |
| 2011 | 62.2 Million CHF | -10.37% |
| 2010 | 69.4 Million CHF | 25.95% |
| 2009 | 55.1 Million CHF | -6.13% |
| 2008 | 58.7 Million CHF | 475.49% |
| 2007 | 12.5 Million CHF | -79.6% |
| 2006 | 51.7 Million CHF | -16.81% |
| 2005 | 60.1 Million CHF | -36.0% |
| 2004 | 93.9 Million CHF | 633.59% |
| 2003 | 12.8 Million CHF | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 5.25 Million CHF | 0.0% |
| 2024 Q1 | 5.25 Million CHF | -71.31% |
| 2023 Q1 | 5.6 Million CHF | -75.11% |
| 2023 Q2 | 11.4 Million CHF | 103.57% |
| 2023 Q4 | 18.3 Million CHF | 122.27% |
| 2023 FY | - CHF | 16.93% |
| 2023 Q3 | 8.23 Million CHF | -27.78% |
| 2022 Q4 | 22.5 Million CHF | 125.38% |
| 2022 Q1 | 800 Thousand CHF | -95.81% |
| 2022 Q2 | 2.2 Million CHF | 175.0% |
| 2022 Q3 | 9.98 Million CHF | 353.79% |
| 2022 FY | - CHF | -17.8% |
| 2021 Q3 | 7.88 Million CHF | -26.32% |
| 2021 Q1 | 5.05 Million CHF | -70.64% |
| 2021 Q2 | 10.7 Million CHF | 111.88% |
| 2021 Q4 | 19.1 Million CHF | 142.28% |
| 2021 FY | - CHF | 35.53% |
| 2020 FY | - CHF | 98.26% |
| 2020 Q2 | 8.9 Million CHF | 111.9% |
| 2020 Q1 | 4.2 Million CHF | 4100.0% |
| 2020 Q4 | 17.2 Million CHF | 146.89% |
| 2020 Q3 | 6.96 Million CHF | -21.72% |
| 2019 Q4 | 100 Thousand CHF | -50.0% |
| 2019 Q3 | 199.99 Thousand CHF | -75.0% |
| 2019 Q2 | 800 Thousand CHF | 0.0% |
| 2019 Q1 | 800 Thousand CHF | -93.6% |
| 2019 FY | - CHF | -71.18% |
| 2018 Q1 | 4.9 Million CHF | -61.79% |
| 2018 Q2 | 4.9 Million CHF | 0.0% |
| 2018 FY | - CHF | -9.93% |
| 2018 Q3 | 13.19 Million CHF | 169.39% |
| 2018 Q4 | 12.5 Million CHF | -5.3% |
| 2017 Q3 | 13.28 Million CHF | 89.76% |
| 2017 FY | - CHF | 211.97% |
| 2017 Q2 | 7 Million CHF | 0.0% |
| 2017 Q1 | 7 Million CHF | 53.85% |
| 2017 Q4 | 12.82 Million CHF | -3.45% |
| 2016 Q1 | 2.65 Million CHF | -76.44% |
| 2016 Q4 | 4.55 Million CHF | 0.0% |
| 2016 FY | - CHF | -69.66% |
| 2016 Q2 | 2.65 Million CHF | 0.0% |
| 2016 Q3 | 4.55 Million CHF | 71.7% |
| 2015 Q2 | 10.3 Million CHF | 0.0% |
| 2015 Q3 | 11.25 Million CHF | 9.22% |
| 2015 FY | - CHF | -26.53% |
| 2015 Q1 | 10.3 Million CHF | -52.42% |
| 2015 Q4 | 11.25 Million CHF | 0.0% |
| 2014 Q1 | 10.65 Million CHF | -40.83% |
| 2014 FY | - CHF | 2.25% |
| 2014 Q4 | 21.65 Million CHF | 0.0% |
| 2014 Q3 | 21.65 Million CHF | 103.29% |
| 2014 Q2 | 10.65 Million CHF | 0.0% |
| 2013 Q4 | 18 Million CHF | 0.0% |
| 2013 Q1 | 13.95 Million CHF | 0.0% |
| 2013 Q2 | 13.95 Million CHF | 0.0% |
| 2013 FY | - CHF | 46.59% |
| 2013 Q3 | 18 Million CHF | 29.03% |
| 2012 FY | - CHF | -31.67% |
| 2011 FY | - CHF | -10.37% |
| 2010 FY | - CHF | 25.95% |
| 2009 FY | - CHF | -6.13% |
| 2008 FY | - CHF | 475.49% |
| 2007 FY | - CHF | -79.6% |
| 2006 FY | - CHF | -16.81% |
| 2005 FY | - CHF | -36.0% |
| 2004 FY | - CHF | 633.59% |
| 2003 FY | - CHF | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 366.645% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | -2.84 Million USD | 879.945% |
| Cannabis Sativa, Inc. | -1.11 Million USD | 2091.866% |
| CompuMed, Inc. | 690.19 Thousand USD | -3116.501% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 89.567% |
| Cogstate Limited | 9.89 Million USD | -124.44% |
| CareView Communications, Inc. | -210.04 Thousand USD | 10669.365% |
| Craneware plc | 54.26 Million USD | 59.086% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 280.597% |
| Certive Solutions Inc. | -704.66 Thousand USD | 3250.438% |
| Drug Free Solution, Inc. | -1.39 Million USD | 1691.481% |
| DATATRAK International, Inc. | 2.72 Million USD | -713.618% |
| Strainsforpains, Inc. | -65.61 Thousand USD | 33936.305% |
| Healixa Inc. | -6.32 Million USD | 451.246% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 10.16 Million USD | -118.319% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 5317.538% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| IQ-AI Limited | -370.35 Thousand USD | 6094.281% |
| Cannabiz Mobile, Inc. | -750.00 USD | 2960100.0% |
| Mednow Inc. | -28.12 Million USD | 178.938% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | 8300.264% |
| MediXall Group, Inc. | -6.52 Million USD | 440.304% |
| Mitesco, Inc. | -11.96 Million USD | 285.566% |
| MobileSmith, Inc. | -13.83 Million USD | 260.434% |
| NantHealth, Inc. | -38.53 Million USD | 157.611% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 1407.42% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | -12.08 Million USD | 283.674% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 283.496% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | -1592.419% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | -29606.945% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | 182306.172% |
| Renalytix Plc | -28.52 Million USD | 177.837% |
| Revium Recovery Inc. | -678 Thousand USD | 3374.336% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | -369.00 USD | 6016360.163% |
| Vaso Corporation | 4.19 Million USD | -429.201% |
| Vynleads, Inc. | -235.72 Thousand USD | 9517.714% |